OptimizeRx Corporation

OptimizeRx Corporation

OPRXยทNASDAQ

$5.53

+11%
HealthcareMedical - Healthcare Information Services

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

At a Glance

Live Snapshot
Market Cap$103.77M
EPS0.2800
P/E Ratio19.75
Earnings Date08/06/2026
OptimizeRx Corporation

OptimizeRx Corporation Fair Value Envelope

OPRX ยท NASDAQ

Our analysis suggests that OPRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.53, this represents a potential HIDDEN relative to our calculated worth for OptimizeRx Corporation.

Intrinsic Value
Current Price: $5.53

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$170.1B
+ Cash & Equivalents$23.4M
Firm Value$170.1B
- Debt$26.1M
Equity Value$170.1B
/ Shares Outstanding18,565,033B
DCF Value$9.2K
UNDERVALUED BY 165539%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$37.4M
$74.9M
$149.7M
$299.4M
$598.9M
$1.2B
$2.4B
$4.8B
$9.6B
$19.2B
Maintenance CapEx
-$23.2K
-$46.4K
-$92.8K
-$185.6K
-$371.2K
-$742.4K
-$1.5M
-$3.0M
-$5.9M
-$11.9M
Owner Earnings
$37.4M
$74.8M
$149.6M
$299.3M
$598.5M
$1.2B
$2.4B
$4.8B
$9.6B
$19.2B
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$34.6M
$64.1M
$118.8M
$220.0M
$407.3M
$754.3M
$1.4B
$2.6B
$4.8B
$8.9B
Terminal Value represents 88.7% of Enterprise Value